STOCK TITAN

TILT Holdings Reports Third Quarter 2024 Results and Announces Strategic Review of its Plant-Touching Business

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

TILT Holdings reported Q3 2024 financial results and announced a strategic review of its plant-touching business. Revenue decreased to $27.0 million from $44.6 million year-over-year, primarily due to delays in Jupiter hardware business shipping and customer transition to commission structure. Gross profit fell to $3.8 million (14% margin) from $8.0 million (18% margin). Net loss widened to $12.6 million from $8.7 million. The company is evaluating strategic alternatives including potential divestitures and partnerships to focus on inhalation technology opportunities and strengthen its balance sheet.

TILT Holdings ha riportato i risultati finanziari del terzo trimestre del 2024 e ha annunciato una revisione strategica delle sue attività legate alle piante. I ricavi sono diminuiti a 27,0 milioni di dollari rispetto ai 44,6 milioni di dollari dello stesso periodo dell'anno precedente, principalmente a causa dei ritardi nelle spedizioni del settore hardware di Jupiter e della transizione dei clienti verso una struttura di commissioni. L'utile lordo è sceso a 3,8 milioni di dollari (margine del 14%) rispetto agli 8,0 milioni di dollari (margine del 18%). La perdita netta si è ampliata a 12,6 milioni di dollari rispetto agli 8,7 milioni di dollari. La società sta valutando alternative strategiche, comprese potenziali cessioni e partnership, per concentrarsi sulle opportunità nel settore della tecnologia di inalazione e rafforzare il proprio bilancio.

TILT Holdings reportó los resultados financieros del tercer trimestre de 2024 y anunció una revisión estratégica de su negocio relacionado con las plantas. Los ingresos disminuyeron a 27,0 millones de dólares desde 44,6 millones de dólares en el año anterior, principalmente debido a retrasos en el envío del negocio de hardware de Jupiter y a la transición de los clientes a una estructura de comisiones. El beneficio bruto cayó a 3,8 millones de dólares (margen del 14%) desde 8,0 millones de dólares (margen del 18%). La pérdida neta se amplió a 12,6 millones de dólares desde 8,7 millones de dólares. La empresa está evaluando alternativas estratégicas, incluidas posibles desinversiones y asociaciones, para centrarse en oportunidades de tecnología de inhalación y fortalecer su balance.

TILT Holdings는 2024년 3분기 재무 결과를 발표하고 식물 관련 사업에 대한 전략적 검토를 발표했습니다. 매출은 작년 같은 기간의 4460만 달러에서 2700만 달러로 감소했으며, 이는 주피터 하드웨어 사업 배송 지연 및 고객의 커미션 구조로의 전환 때문입니다. 총 이익은 380만 달러 (14% 마진)로 떨어졌고, 이는 800만 달러 (18% 마진)에서 감소한 것입니다. 순손실은 1260만 달러로 확대되었으며, 이는 870만 달러에서 증가한 수치입니다. 회사는 흡입 기술 기회를 다루고 재무구조를 강화하기 위해 잠재적인 매각 및 파트너십을 포함한 전략적 대안을 평가하고 있습니다.

TILT Holdings a publié les résultats financiers du troisième trimestre 2024 et a annoncé un examen stratégique de ses activités liées aux plantes. Les revenus ont diminué pour atteindre 27,0 millions de dollars contre 44,6 millions de dollars l'année précédente, principalement en raison des retards d'expédition de l'activité matérielle de Jupiter et de la transition des clients vers une structure de commission. Le bénéfice brut a chuté à 3,8 millions de dollars (marge de 14%) contre 8,0 millions de dollars (marge de 18%). La perte nette s'est élargie à 12,6 millions de dollars contre 8,7 millions de dollars. L'entreprise évalue des alternatives stratégiques, y compris d'éventuelles cessions et partenariats, afin de se concentrer sur les opportunités technologiques liées à l'inhalation et de renforcer son bilan.

TILT Holdings hat die finanziellen Ergebnisse für das 3. Quartal 2024 veröffentlicht und eine strategische Überprüfung seines pflanzenbezogenen Geschäfts angekündigt. Die Einnahmen sanken im Vergleich zum Vorjahr von 44,6 Millionen Dollar auf 27,0 Millionen Dollar, hauptsächlich aufgrund von Verzögerungen beim Versand im Jupiter-Hardwaregeschäft und dem Übergang der Kunden zu einem Provisionsmodell. Der Bruttogewinn fiel auf 3,8 Millionen Dollar (14% Marge) von 8,0 Millionen Dollar (18% Marge). Der Nettoverlust weitete sich auf 12,6 Millionen Dollar aus, gegenüber 8,7 Millionen Dollar. Das Unternehmen prüft strategische Alternativen, einschließlich potenzieller Veräußerungen und Partnerschaften, um sich auf Chancen im Bereich Inhalationstechnologie zu konzentrieren und seine Bilanz zu stärken.

Positive
  • Cash from operating activities increased to $2.0 million from $1.0 million year-ago
  • Cash and equivalents improved to $3.9 million from $3.3 million at year-end 2023
  • Implementation of asset-light model for Jupiter to improve working capital position
Negative
  • Revenue declined 39.5% year-over-year to $27.0 million
  • Gross margin decreased to 14% from 18% year-over-year
  • Net loss increased to $12.6 million from $8.7 million year-over-year
  • Adjusted EBITDA turned negative at $(1.6) million from positive $2.2 million

PHOENIX, Nov. 14, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (Cboe CA: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, is reporting its financial and operating results for the three months ended September 30, 2024. TILT is also announcing that it is underway with a review of strategic alternatives for its plant-touching business.

All financial information is reported in U.S. dollars and prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) unless otherwise indicated.

“We are underway with a comprehensive strategic review of our plant-touching business,” announced TILT’s Chief Executive Officer Tim Conder. “This process allows us to evaluate a range of potential actions, including divestitures, partnerships, and other strategic alternatives, to align our portfolio better and focus on our opportunity in inhalation technology. We believe that these plant-touching assets hold significant potential value for other operators and could provide us with the additional capital needed to strengthen our balance sheet and expand Jupiter Research.”

“Further, we are also highlighting key management changes that will further support our long-term vision and strategic objectives. Ken Yuan has been an integral part of our team as Jupiter’s Chief Operating Officer since earlier this year. Ken has extensive operational and restructuring experience and is driving increased efficiency and focus across our organization. Additionally, we have brought on Khalid Al Naser as head of our commercial efforts for TILT. Khalid adds deep experience in the cannabis vaporization space, most recently as co-founder of Raw Garden, and we are confident that his leadership will be a true value add for TILT and our customers.”

Conder concluded, “During the third quarter, we worked through our new ‘asset-light’ model for Jupiter which we introduced in Q2. This model allows for a just-in-time production and shipping structure, which we expect should improve our working capital position. That said, we believe that by continuing to evolve Jupiter, and with this strategic review process completed, it will allow us to sharpen our focus, better align our resources, and build a robust portfolio of products that meets our customers’ evolving pricing and innovation needs.”

Q3 2024 Financial Summary

  • Revenue was $27.0 million in the three months ended September 30, 2024, compared to $44.6 million in the prior year period. The decrease in revenue was primarily driven by the Company’s Jupiter hardware business related to delays in shipping from a primary supplier as well as the temporary transition of certain customers to a commission structure.
  • Gross profit was $3.8 million and gross margin was 14% in the three months ended September 30, 2024, compared to $8.0 million or 18% of revenue in the prior year period. The decrease in gross profit was mainly driven by the decreased sales volume, whereas the decrease in gross margin was primarily driven by increased logistics costs related to shipping delays, as well as product mix.
  • Net loss was $12.6 million in the three months ended September 30, 2024, compared to a net loss of $8.7 million in the prior year period.
  • Adjusted EBITDA (non-GAAP) was $(1.6) million in the three months ended September 30, 2024, compared to $2.2 million in the prior year period. The decrease was primarily driven by lower revenue and gross margin.
  • Cash provided by operating activities in the third quarter was $2.0 million compared to $1.0 million for the year-ago period.
  • At September 30, 2024, the Company had $3.9 million of cash, cash equivalents and restricted cash compared to $3.3 million at December 31, 2023.

Q3 2024 & Recent Operational Highlights

  • Launched Edie Parker Flower in the Pennsylvania in the third quarter.
  • Announced the appointment of Marshall Horowitz to the board of directors following the resignation of Adam Draizin.
  • Announced the departure of Chris Kelly, former Chief Revenue Officer.

Strategic Alternatives

The Company is undertaking a process to review strategic alternatives for its plant-touching assets. These alternatives could include, among others, possible joint ventures, strategic partnerships, or sale. The intent is to optimize the Company’s portfolio of businesses and create value for stakeholders. This decision was made as part of our continual strategic portfolio analysis, which is focused on positioning the Company to serve high growth markets and to restructure its balance sheet. As we undertake this review, the Company remains committed to executing on our current plant-touching business plans and serving the needs of our customers.

There is no deadline or definitive timetable for completion of the strategic alternatives review process and there can be no assurance that this process will result in the Company pursuing a transaction or any other strategic outcome. The Company does not intend to make any further public comment regarding the review of strategic alternatives for its plant-touching assets until it has been completed or the Company determines that a disclosure is required or otherwise deemed appropriate.

Earnings Call and Webcast

TILT management will host a conference call today at 5:00 p.m. Eastern time to discuss its financial and operational results.

Date: Thursday, November 14th, 2024,
Time: 5:00 p.m. Eastern Time
Toll-free dial-in number: (877) 423-9813
International dial-in number: (201) 689-8573
Webcast: TILT Q3 2024 Earnings Call

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Elevate IR at (720) 330-2829.

The conference call will also be available for replay in the investor relations section of the Company’s website at www.tiltholdings.com.

About TILT

TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 40 states in the U.S., as well as Canada, Israel, Mexico, South America and the European Union. TILT’s core businesses include Jupiter Research LLC, a wholly-owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations, Commonwealth Alternative Care, Inc. in Massachusetts, Standard Farms LLC in Pennsylvania, and Standard Farms Ohio, LLC in Ohio. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com.

Forward-Looking Information

This news release contains forward-looking information and statements (together, “forward-looking information”) under applicable Canadian and U.S. securities laws which are based on current expectations. Forward-looking information is provided for the purpose of presenting information about TILT management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward-looking information may include, without limitation, outcome of the Company’s strategic review of plant-touching assets, increased focus and growth of Jupiter in relation to any potential divestiture of the plan touching assets, strengthening of TILT’s balance sheet, expectations relating to the impact of the leadership change on TILT’s operations, TILT’s beliefs about working through the leadership transition, TILT’s expectations on reductions in corporate overhead and headcount and re-alignment of its business, TILT’s business strategy and growth opportunities, the opinions or beliefs of management, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies, and outlook of TILT, and includes statements about, among other things, future developments, the future operations, strengths and strategy of TILT. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “will”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. These statements should not be read as guarantees of future performance or results. These statements are based upon certain material factors, assumptions and analyses that were applied in drawing a conclusion or making a forecast or projection, including TILT’s experience and perceptions of historical trends, the ability of TILT to maximize shareholder value, current conditions and expected future developments, as well as other factors that are believed to be reasonable in the circumstances.

Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. TILT assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

By its nature, forward-looking information is subject to risks and uncertainties, and there are a variety of risk factors, many of which are beyond the control of TILT, and that may cause actual outcomes to differ materially from those discussed in the forward-looking information. Such risk factors include, but are not limited to, TILT’s ability to find a permanent successor executive, the impact of the announcement of the leadership change on TILT’s stock, performance, operations, results of operations, employees, suppliers and customers, TILT’s ability to successfully work through the leadership transition, TILT’s ability to execute on its business optimization strategy, capital preservation and cash generation, and reductions in corporate overhead and headcount and re-alignment of its business and those risks described under the heading “Item 1A Risk Factors” in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and “Item 1A Risk Factors” in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 and other subsequent reports filed by TILT with the United States Securities and Exchange Commission at www.sec.gov and on SEDAR+ at www.sedarplus.ca.

Company Contact:

Lynn Ricci, VP of Investor Relations & Corporate Communications
TILT Holdings Inc.
lricci@tiltholdings.com

Investor Relations Contact:

Sean Mansouri, CFA
Elevate IR
TILT@elevate-ir.com
720.330.2829


Table 1: Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
(Amounts Expressed in Thousands of United States Dollars)
                
     
 Three Months Ended  Nine Months Ended 
 September 30, June 30, September 30, September 30, September 30, 
 2024  2024  2023  2024  2023  
Revenues, net$26,967  $26,581  $44,555  $91,052  $128,418  
Cost of goods sold (23,172)  (22,322)  (36,595)  (76,281)  (107,622) 
Gross profit  3,795   4,259   7,960   14,771   20,796  
                
Operating expenses:               
Wages and benefits 4,453   4,637   4,707   13,586   16,362  
General and administrative 2,691   3,323   3,721   9,497   13,870  
Sales and marketing 140   187   175   469   869  
Share-based compensation 131   23   190   261   (1,875) 
Depreciation and amortization 3,856   3,862   3,891   11,584   12,732  
Impairment loss and loss on disposal of assets    15,728      15,740   5,135  
Total operating expenses 11,271   27,760   12,684   51,137   47,093  
Operating loss (7,476)  (23,501)  (4,724)  (36,366)  (26,297) 
                
Other (expense) income:               
Interest income    1      3     
Other income 105   510   2   819   102  
Gain (loss) on sale of assets and membership interests       483      8,884  
Unrealized loss on investment       (1)  (1)  (6,401) 
Loan receivable losses       (14)     (5,602) 
Loss on foreign currency exchange       (17)  (4)  (18) 
Interest expense (6,683)  (6,792)  (6,369)  (19,518)  (15,927) 
Total other (expense) income (6,578)  (6,281)  (5,916)  (18,701)  (18,962) 
Loss from operations before income tax and non-controlling interest (14,054)  (29,782)  (10,640)  (55,067)  (45,259) 
                
Income taxes               
Income tax benefit (expense) 1,405   (6,165)  1,977   (3,180)  3,393  
Net loss before non-controlling interest (12,649)  (35,947)  (8,663)  (58,247)  (41,866) 
Less: Net income attributable to non-controlling interest             1,433  
Net loss attributable to TILT Holdings Inc. $(12,649) $(35,947) $(8,663) $(58,247) $(40,433) 
                



Table 2: Reconciliation of Non-GAAP Measures (Unaudited)
(Amounts Expressed in Thousands of United States Dollars)
                
                
 Three Months Ended  Nine Months Ended 
 September 30, 2024 June 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023 
Net (loss) income before non-controlling interest$(12,649) $(35,947) $(8,663) $(58,247) $(41,866) 
                
Add (Deduct) Impact of:               
Interest income    (1)     (3)    
Interest expense 6,683   6,792   6,369   19,518   15,927  
Income tax expense (benefit) (1,405)  6,165   (1,977)  3,180   (3,393) 
Depreciation and amortization 5,356   5,682   5,738   16,722   18,413  
Total Adjustments 10,634  -18,638   10,130   39,417   30,947  
                
EBITDA (Non-GAAP)$(2,015) $(17,309) $1,467  $(18,830) $(10,919) 
                
Add (Deduct) Impact of:               
Share-based Compensation 131   23   190   261   (1,875) 
Severance 48   8   130   69   1,080  
(Gain) Loss on Sale of Assets       (483)     (8,884) 
Legal Settlement             258  
Unrealized Loss on Investment in Equity Security       1   1   6,401  
Loss on Loan Receivable       14      5,602  
Impairment Loss and Loss on Disposal of Assets    15,728      15,740   5,135  
Foreign Exchange (Gain) Loss       17   4   18  
Non-Cash Inventory Adjustment 270   215   734   498   5,831  
One Time Bad Debt Expense             384  
One Time Adjustments    141   171   (465)  670  
Total Adjustments 449   16,115   774   16,108   14,620  
                
Adjusted EBITDA (Non-GAAP) (1,566)  (1,194)  2,241   (2,722)  3,701  
                
Net Loss Before Non-Controlling Interest (12,649)  (35,947)  (8,663)  (58,247)  (41,866) 
Add (Deduct) Impact of:               
Impairment Loss and Loss on Disposal of Assets    15,728      15,740   5,135  
Adjusted Net Loss Before Non-Controlling Interest (12,649)  (20,219)  (8,663)  (42,507)  (36,731) 
                



Table 3: Condensed Consolidated Statements of Cash Flows (Unaudited)
(Amounts Expressed in Thousands of United States Dollars)
       
       
  Nine Months Ended 
  September 30, 2024  September 30, 2023 
Net Cash (Used in) Provided by Operating Activities$319  $1,391  
Net Cash (Used in) Provided by Investing Activities (451)  13,243  
Net Cash Provided by (Used in) Financing Activities 717   (15,337) 
Effect of Foreign Exchange on Cash and Cash Equivalents (8)  (14) 
Net Change in Cash and Cash Equivalents 577   (717) 
       
Cash and Cash Equivalents and Restricted Cash, Beginning of Period 3,332   3,500  
       
Cash and Cash Equivalents and Restricted Cash, End of Period$3,909  $2,783  
       



Table 4: Condensed Consolidated Balance Sheets (Select Items)
(Amounts Expressed in Thousands of United States Dollars) 
         
         
 Periods Ended  
  September 30, 2024
  December 31, 2023
 
  (unaudited)   (audited)  
Cash and Cash Equivalents$2,609  $2,034  
Restricted Cash 1,300   1,298  
Trade Receivables and Others 10,332   17,919  
Inventories 22,922   32,908  
Total Current Assets 39,756   56,274  
Property, Plant & Equipment, Net 31,704   51,185  
Total Assets 182,594   231,188  
Total Current Liabilities 83,443   76,072  
Total Long-Term Liabilities 94,750   92,723  
Total Shareholders’ Equity 4,401   62,393  
         


Reconciliation of Non-GAAP Measures for Gross Profit         
(Amounts Expressed in Thousands of United States Dollars)        
               
     
 Three Months Ended  Nine Months Ended 
 September 30, June 30,  September 30, September 30,September 30, 
 2024  2024  2023  2024 2023  
Revenues, net$26,967  $26,581  $44,555  $91,052 $128,418  
Cost of goods sold (23,172)  (22,322)  (36,595)  (76,281) (107,622) 
Gross profit $ 3,795   4,259   7,960   14,771  20,796  
Gross profit % 14.1%  16.0%  17.9%  16.2% 16.2% 
               
Add (Deduct) Impact of:              
One-Time Adjustment*          (717)   
Non-Cash Inventory Adjustment 270   215   734   498  5,831  
Total Adjustments 270   215   734   (219) 5,831  
               
Adjusted Gross Profit $ (Non-GAAP) 4,065   4,474   8,694   14,552  26,627  
Adjusted Gross Profit % (Non-GAAP) 15.1%  16.8%  19.5%  16.0% 20.7% 
               
* One-time adjustment related to Taunton's Host Fee Reversal          
               

FAQ

What was TILT Holdings (TLLTF) revenue in Q3 2024?

TILT Holdings reported revenue of $27.0 million in Q3 2024, down from $44.6 million in the same period last year.

What strategic alternatives is TILT Holdings (TLLTF) considering for its plant-touching business?

TILT is evaluating options including joint ventures, strategic partnerships, or sale of its plant-touching business to optimize its portfolio and focus on inhalation technology.

Why did TILT Holdings (TLLTF) gross margin decline in Q3 2024?

Gross margin declined to 14% from 18% due to increased logistics costs related to shipping delays and changes in product mix.

TILT HLDGS INC

OTC:TLLTF

TLLTF Rankings

TLLTF Latest News

TLLTF Stock Data

2.87M
319.43M
7.94%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Phoenix